Hostname: page-component-848d4c4894-xm8r8 Total loading time: 0 Render date: 2024-07-01T10:00:16.506Z Has data issue: false hasContentIssue false
  • English
  • Français

Flunarizine as a Supplementary Medication in Refractory Childhood Epilepsy: A Double-Blind Crossover Study

Published online by Cambridge University Press:  18 September 2015

D. Keene ,
S. Whiting ,
P. Humphreys  and
P. Jacob
D. Keene*
Affiliation:
Section of Neurology, Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa
S. Whiting
Affiliation:
Section of Neurology, Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa
P. Humphreys
Affiliation:
Section of Neurology, Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa
P. Jacob
Affiliation:
Section of Neurology, Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa
*
Section of Neurology, Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada K1H 8L1
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

We report a double blinded cross-over study involving Flunarizine versus placebo in the treatment of refractory childhood epilepsy. The patients studied were between the ages of 2 and 18; and were having more than 4 seizures per month not responsive to regular anticonvulsant medications. Of the 34 patients treated, 8 had a 50% decrease in their seizures during the placebo phase, 5 had a 50% decrease during the Flunarizine phase, and 1 patient had a 50% increase in seizures while taking Flunarizine. The remaining 25 patients showed no change in seizure activity in either phase. Patients having partial seizures with secondary generalization tended to do better on Flunarizine than those with other seizure types. Monitoring serum Flunarizine levels showed no significant difference between patients having improved seizure control and those who were unimproved. No significant side effects were noted with this medication, nor were any significant drug interactions noted.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 16 , Issue 2 , May 1989 , pp. 191 - 193
Copyright
Copyright © Canadian Neurological Sciences Federation 1989

References

REFERENCES

1.Meldrum, B, et al. Hypoxia and neuronal hyperexcitability, a clue lo mechanisms of brain protection. In: Wanquier, A, et al. eds. Protection of Tissue against Hypoxia: Amsterdam: Elsevier Biomedical Press. 1984; 27.Google Scholar
2.Ashton, D, Marrannes, R, Pauwels, PJ. et al. Possible mechanisms of Flunarizine's anticonvulsant activity. In: nternational Workshop on Flunarizine in Epilepsy: Health Science Review Beerse 1985; 45–59.Google Scholar
3.Ashton, D, Wanquier, A. Effects of some anti-epileptic neuroloptic and gabaminergic drugs on seizures induced by D.L-allylglycerine. Pharmacol Biochem Behavior 1979; 2: 221–226.CrossRefGoogle Scholar
4.Ashton, D, Wanquier, A, Behavior analysis of effects of 15 anticonvulsants in the amygdaloid kindled rais. Psychopharmacology 1979; 65: 7–13.CrossRefGoogle Scholar
5.Desmedt, LK, Niemeggers, CJE, Jansseen, PAJ, Anticonvulsive properties of cinnarizine and Flunarizine in rals and mice. Arnzeimittel-Forschung 1975; 25: 1408–1413.Google Scholar
6.Declerk, AC, Wanquier, A. Double-blind study of the effectiveness of Flunarizine in therapy resistant epilepsy in mentally retarded children. In: Wada, JA. Penry, JK, et al, eds. Advances in Epileptology: New York: Raven Press 1980; 356.Google Scholar
7.Binnie, CD, De Beukelaar, F, et al. Open dose ranging trial of Flunarizine as add-on therapy in epilepsy. Epilepsia 1985; 26: 424–428.CrossRefGoogle ScholarPubMed
8.Curatolo, P, Cusmai, R, et al. Flunarizine in therapy resistant epilepsies of infancy and childhood. International Congress on Migraine and Epilepsia (abst). Rome 1986.Google Scholar
9.Sorel, L, Flunarizine, comme medication complementaire dans les epilepsies rebelles etude ouverte. Contra a Epilepsia (absl) 1986.Google Scholar
10.Overweg, J, et al. Double-blind placebo-controlled trial of Flunarizine as add-on therapy in epilepsy. Epilepsia 1984a; 25: 217–222.CrossRefGoogle ScholarPubMed
11.Froscher, W, Bulau, P, Burr, W, et al. Double-blind placebo controlled trial of Flunarizine in therapy resistant epileptic patients. In: International Workshop on Flunarizine in Epilepsy. Health Science Review Beerse. 1985; 81–88.Google Scholar
12.Cavazzutti, GB, Galli, V, Benatti, A. Use of Flunarizine in pediatric epilepsy. International Congress on Migraine and Epilepsia (abst). Rome 1986.Google Scholar